|
Q3 FY2022
As of Mar 31, 2022
|
Q2 FY2022
As of Dec 31, 2021
|
Q1 FY2022
As of Sep 30, 2021
|
Q4 FY2021
As of Jun 30, 2021
|
Q3 FY2021
As of Mar 31, 2021
|
Q2 FY2021
As of Dec 31, 2020
|
Q1 FY2021
As of Sep 30, 2020
|
Q4 FY2020
As of Jun 30, 2020
|
Q3 FY2020
As of Mar 31, 2020
|
Q2 FY2020
As of Dec 31, 2019
|
Q1 FY2020
As of Sep 30, 2019
|
Q4 FY2019
As of Jun 30, 2019
|
Q3 FY2019
As of Mar 31, 2019
|
Q2 FY2019
As of Dec 31, 2018
|
Q1 FY2019
As of Sep 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Account receivable - related parties | |||||||||||||||
| Accounts receivable, net | |||||||||||||||
| Other receivables, net | |||||||||||||||
| Related party receivable | |||||||||||||||
| Prepayment and other current assets, net | |||||||||||||||
| Inventories | |||||||||||||||
| Advance to suppliers | |||||||||||||||
| Advance to suppliers - related parties | |||||||||||||||
| Prepaid taxes | |||||||||||||||
| Total current assets | |||||||||||||||
| Non-current assets | |||||||||||||||
| Property and equipment, net | |||||||||||||||
| Intangible assets, net | |||||||||||||||
| Right-of-use assets | |||||||||||||||
| Total non-current assets | |||||||||||||||
| Total Assets | |||||||||||||||
| Liabilities and Stockholders’ Deficit | |||||||||||||||
| Current liabilities | |||||||||||||||
| Accounts payable | |||||||||||||||
| Loan payable - related party | |||||||||||||||
| Due to related party | |||||||||||||||
| Deferred revenues | |||||||||||||||
| Taxes payable | |||||||||||||||
| Accrued liabilities and other payables | |||||||||||||||
| Advance from customers | |||||||||||||||
| Related party payable | |||||||||||||||
| Lease payable-current portion | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Lease payable- non-current | |||||||||||||||
| Total Liabilities | |||||||||||||||
| Commitments and contingencies | |||||||||||||||
| Stockholders’ Deficit | |||||||||||||||
| Series A Preferred Stock, 10,000,000 shares authorized at $0.001 per share: 9,920,000 shares issued and outstanding as of March 31, 2022 and June 30, 2021, respectively | |||||||||||||||
| Common stock, par value $0.001 per share; 500,000,000 shares authorized; 110,319,245 shares issued and outstanding as of March 31, 2022 and June 30, 2021, respectively | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Shares Subscription Receivable | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Total Stockholders’ Deficit | |||||||||||||||
| Total Liabilities and Stockholders’ Deficit | |||||||||||||||
Loading...
